Home LiteratureArticle Details
PMID: 17371959 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 178 ·No. 7 ·2007-04-01 ·Pages 4051-61

Hilchey SP, De A, Rimsza LM, Bankert RB, Bernstein SH

Abstract

Regulatory T cells (T(R)) play a critical role in the inhibition of self-reactive immune responses and as such have been implicated in the suppression of tumor-reactive effector T cells. In this study, we demonstrate that follicular lymphoma (FL)-infiltrating CD8+ and CD4+ T cells are hyporesponsive to CD3/CD28 costimulation. We further identify a population of FL-infiltrating CD4+CD25+GITR+ T(R) that are significantly overrepresented within FL nodes (FLN) compared with that seen in normal (nonmalignant, nonlymphoid hyperplastic) or reactive (nonmalignant, lymphoid hyperplastic) nodes. These T(R) actively suppress both the proliferation of autologous nodal CD8+CD25- and CD4+CD25- T cells, as well as cytokine production (IFN-gamma, TNF-alpha and IL-2), after CD3/CD28 costimulation. Removal of these cells in vitro by CD25+ magnetic bead depletion restores both the proliferation and cytokine production of the remaining T cells, demonstrating that FLN T cell hyporesponsiveness is reversible. In addition to suppressing autologous nodal T cells, these T(R) are also capable of suppressing the proliferation of allogeneic CD8+CD25- and CD4+CD25- T cells from normal lymph nodes as well as normal donor PBL, regardless of very robust stimulation of the target cells with plate-bound anti-CD3 and anti-CD28 Abs. The allogeneic suppression is not reciprocal, as equivalent numbers of CD25+FOXP3+ cells derived from either normal lymph nodes or PBL are not capable of suppressing allogeneic CD8+CD25- and CD4+CD25- T cells, suggesting that FLN T(R) are more suppressive than those derived from nonmalignant sources. Lastly, we demonstrate that inhibition of TGF-beta signaling partially restores FLN T cell proliferation suggesting a mechanistic role for TGF-beta in FLN T(R)-mediated suppression.

MeSH Terms
CD28 Antigens/analysis,immunology CD3 Complex/analysis,immunology CD4 Antigens/analysis Cell Separation Cytokines/metabolism Glucocorticoid-Induced TNFR-Related Protein Humans Immune Tolerance Immunosuppression Therapy Interleukin-2 Receptor alpha Subunit/analysis Lymph Nodes/cytology,immunology Lymphocytes, Tumor-Infiltrating/chemistry,immunology Lymphoma, Follicular/immunology Receptors, Antigen, T-Cell/agonists Receptors, Nerve Growth Factor/analysis Receptors, Tumor Necrosis Factor/analysis T-Lymphocytes, Regulatory/chemistry,immunology Transforming Growth Factor beta/metabolism
Chemicals
CD28 Antigens CD3 Complex CD4 Antigens Cytokines Glucocorticoid-Induced TNFR-Related Protein Interleukin-2 Receptor alpha Subunit Receptors, Antigen, T-Cell Receptors, Nerve Growth Factor Receptors, Tumor Necrosis Factor TNFRSF18 protein, human Transforming Growth Factor beta
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Hilchey Shannon P
James P. Wilmot Cancer Center, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.
De Asit
Rimsza Lisa M
Bankert Richard B
Bernstein Steven H
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
2007-04-01
Pages
4051-61
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NCI NIH HHS · R01 CA 10897 · United States
NIGMS NIH HHS · R01 GM 65237 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]